Home Add to Favorite Contact Submit  
           22 May, 2022


    
Category:  Press » Technology

 

Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform

Popularity:
         Views: 1350
2009-01-05 03:15:59     
Bionovo, Inc.

Bionovo, Inc. (Nasdaq: BNVI) announced today results describing predictable estrogen regulatory elements that can be used to identify estrogenic drugs that are safer. The data, published in Molecular and Cellular Endocrinology, showed that the new regulatory elements can distinguish the estrogenic pharmacological activity exerted by different compounds and allow for more accurate prediction of specific tissue effect.

"Selective estrogen modulators (SERMs) are an exciting class of drugs that are used to prevent breast cancer and osteoporosis and differ from estrogens in how they regulate gene transcription," said Dr. Dale Leitman, from the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco. "This study identified gene elements that are activated by SERMs but not by estrogens used in hormone therapy. The identification of these elements, coupled with the understanding of the differential regulation in various tissues by each estrogen receptor subtype, provides a new platform for the discovery of safer estrogenic drugs with SERM-like profiles to prevent and treat a variety of clinical conditions associated with menopause."

The study was conducted by investigators at The Center for Reproductive Sciences in the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco in collaboration with scientists at Bionovo.

"The discovery of these selective estrogen regulatory elements strengthens our SERM discovery engine," said Isaac Cohen, Bionovo's Chairman and Chief Executive Officer. "The advantage of the new array, of specific regulatory elements, is manifest in the pharmacological and toxicological insights gained. We can now acquire higher predictive value and greater specificity from a complex biological system such as the regulation of the estrogen receptor pathways. I believe this puts Bionovo at the forefront of future SERM products which are far more specific and a more favorable safety profile. This is a breakthrough for all future drugs that regulate the vast diverse effects of conditions affected by nuclear receptors. Bionovo is positioned to explore and exploit these pathways for many serious diseases with its expanded scientific collaborations. We are proud to continue pursuing our innovative approaches to drug discovery and development in these challenging times."

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Specialized in: Bionovo - Predictable Tissue Selectivity - Selective Estrogen Receptor - Modulators Platform
URL: http://www.bionovo.com
Print press release      Bookmark this page
Related Press releases 
Artis Launches a New Website for a Better Shopping Experience (Popularity: ): Artis is a new-age brand for audio products that provide listeners a clear, rich, and powerful experience.Mumbai, Maharashtra - India | December 10, 2020 -- Artis is a new-age brand for audio products that provide listeners a clear, rich, and powerful experience. Launched in June 2020, the brand has started a new journey amid the coronavirus pandemic and yet are set on the right direction. The brand launched its new ...
Microchip Introduces 3kW Transient Voltage Suppressor Diode Array Family for Superior Circuit Protection in Harsh Environments (Popularity: ): June 17, 2020, New Delhi – To ensure critical operations, aviation and space systems rely on digital and logic functionality and circuitry in engine control units, environmental controls, instruments and actuators. Data centers, the 5G infrastructure and communication systems also rely on complex circuitry requiring protection. Each system must operate continuously despite voltage surges and spikes from lightning, solar events and electromagnetic incidents. Microchip Technology Inc. (Nasdaq: MCHP) today announced ...
Axle ai Launches Remote Work Solution for Avid Media Composer (Popularity: ): Boston, MA - USA, June 10, 2020 -- axle ai, an industry-leading developer of software that makes video searchable, has announced a new Pro option for its axle ai 2020 software that supports Avid’s Media Composer professional editing software. With the new axle ai 2020 Pro module, Avid editors now have the powerful new capability of accessing both native Avid media and a wide range of other media remotely, through ...
Microchip Announces the 53100A Phase Noise Analyzer for Precision Oscillator Characterization (Popularity: ): New Delhi, May 5th, 2020 – To help research and manufacturing engineers make precise and accurate measurement of frequency signals, including those generated by atomic clocks and other high-performance frequency reference modules and subsystems, Microchip Technology Inc. (Nasdaq: MCHP) today announced the availability of the new 53100A Phase Noise Analyzer, a next-generation phase noise test instrument. The 53100A Phase Noise Analyzer is designed for engineers and scientists who rely on ...
Munich service robot can provide support during the COVID 19 pandemic (Popularity: ): Munich, Bavaria ( press.abc-directory.com ) April 8, 2020 - The technology company Robotise wants to help quickly alleviate current staff shortages in hospitals, doctors' practices and nursing homes.The company is modifying its JEEVES service robot for this purpose. The 1.10-meter-high robot has been used primarily for minibar and room service in hotels until now. But the robotic butler will now be used as an autonomous assistant for the health sector. ...

Press release home snapshot 


Related Business 
Eprosartan Mesylate ( Teveten ) By Solvay Pharmaceuticals, Inc. (Popularity: ): An angiotensin II receptor antagonist, which acts specifically on the receptor that triggers increased blood pressure. Intended for physicians in the Philippines.
Selective Genetics (Popularity: ): Aims to commercialize site-specific gene therapeutics and DNA devices for tissue repair and regeneration.
Estrogen Source (Popularity: ): Find information and products helping you to naturally balance your hormones and treat your symptoms of menopause. If you're looking to balance your high or low estrogen levels and other hormones naturally, and you'd like to improve your health, you've come to the right place.
Ultrasonic Systems Incorporated (Popularity: ): Manufactures spray coating systems based upon ultrasonic spray technology. Products include a selective coating system platform, a selective fluxing line for the wave soldering process and a web coating line for the glass, steel, paper and textile industries.
Toilet Tissue & Toilet Tissue Dispensers (Popularity: ): Toilet tissue has universal application. Toilet paper is a soft paper product used to maintain personal hygiene after human defecation or urination. The holders in many public toilets are designed to make it difficult to steal the toilet paper and Tissue.
Nakako Design Private Limited (Popularity: ): Happy Tissue is tissue advertising and marketing specialist in Singapore. Tissue Advertising has been proven as an effective way of getting your message out. Offering the best price that no one in the market is even close.
Satinwrap Homepage (Popularity: ): Supplies wrapping tissue, printed tissue, printed cello, printed giftwrap and tissue display racks.
HistoRx (Popularity: ): HistoRx has developed an automated, integrated tissue analysis system that enables objective, quantitative, and localized analysis of protein expression within the subcompartments of cells in tissue samples and tissue microarrays.
Tissue Banks International (TBI) (Popularity: ): Non-profit network of eye and tissue banks. Provide corneas and other eye tissue for sight-reconstruction surgery.
Tarrytech Computer Consultants (Popularity: ): Tarrytech Computer Consultants is the premier technology partner in the NY Metro area. Our exceptional blend of people, products, and processes delivers efficient, stable, and predictable results with all of your information systems – and we do it all at a predictable price, something most technology consulting firms can’t offer.